Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Everest Global Plc, a distinguished player in the insurance and reinsurance industry, primarily offers comprehensive risk management solutions worldwide. The company focuses on underwriting various insurance policies, covering a diverse array of sectors such as property, casualty, and specialty lines, which include professional liability, healthcare, and marine insurance. Its reinsurance segment addresses critical needs for risk-sharing among primary insurance providers, aiding global insurers in enhancing their service range and financial stability. Everest Global Plc operates from strategic locations, leveraging its global presence to understand local market dynamics and client needs effectively. It plays a crucial role in the financial market by providing essential risk management solutions that facilitate business continuance and economic stability. The firm’s ability to underwrite significant risks and offer tailored policies underscores its importance in maintaining resilience across industries. Headquartered in the UK, Everest Global Plc is recognized for its robust financial performance and adherence to regulatory standards, contributing to industry standards in risk assessment and management. The company's strategic initiatives and market insights ensure its position as a key entity in the global insurance and reinsurance landscapes.
£1.20
+£0.00 (+0.00%)
EOD Jul 3, 2026
The business is unprofitable at the operating level (-152.93% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
At 83x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Negative free cash flow of -£726K. The business is consuming cash, not generating it.
83.3x earnings. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£438K
Net Income (TTM)
£4M
▲ +565.1% YoY
Op. Margin
-152.93%
ROIC
-11.59%
Cash Flow & Balance Sheet
FCF (TTM)
-£726K
▼ -24.6% YoY
Op. Cash Flow (TTM)
-£642K
▼ -10.1% YoY
Net Debt
£3M
Cash & Equiv.
£280K
3Y CAGR: -32.2%
Continue Research
At a P/E of 83.3, Everest Global (EVST.XLON)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Everest Global scores 4/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Everest Global scores 4 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -152.9% operating margin and a -11.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh EVST.XLON's valuation and scores 4/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.